David O’Reilly

David O’Reilly is co-founder and Chief Executive Officer of Cavalon Therapeutics, a biotechnology company focused on discovering new solutions for neurological disorders. He has over 25 years of experience as an entrepreneur and executive in the life sciences industry and in the founding, financing, scaling and partnering of innovative pharmaceutical, medical device and digital health companies. Prior to Cavalon, David held executive roles at Proteus Digital Health, Catalyst Biosciences, Iconix Biosciences, ARIAD Pharmaceuticals and L.E.K. Consulting.

David earned an MBA from Harvard Business School, where he graduated with Distinction, and a BA from Wesleyan University, where he was named the Gilbert H. Clee Scholar.